Morphine Reduces the Threshold of Helium Preconditioning Against Myocardial Infarction: The Role of Opioid Receptors in Rabbits

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 23, Issue 5, 2009, Pages 619-624

  Pagel, Paul S ^a   Krolikowski, John G ^a   Amour, Julien ^a   Warltier, David C ^a   Weihrauch, Dorothee ^a  

^a CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

helium; morphine; myocardial ischemia; opioid receptor; preconditioning

Indexed keywords

HELIUM; HEPARIN; MORPHINE; NALOXONE; OPIATE RECEPTOR; OXYGEN;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; HEART INFARCTION; HEMODYNAMICS; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; DRUG INTERACTIONS; HELIUM; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MORPHINE; MYOCARDIAL REPERFUSION INJURY; PROSPECTIVE STUDIES; RABBITS; RECEPTORS, OPIOID;

EID: 67649596881     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2008.12.020     Document Type: Article

References (35)

1. Preckel B., Weber N.C., Sanders R.D., et al. Molecular mechanisms transducing the anesthetic, analgesic, and organ-protective actions of xenon. Anesthesiology 105 (2006) 187-197
2. Pagel P.S., Krolikowski J.G., Venkatapuram S., et al. Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo. Anesth Analg 105 (2007) 562-569
3. Coburn M., Maze M., and Franks N.P. The neuroprotective effects of xenon and helium in an in vitro model of traumatic brain injury. Crit Care Med 36 (2008) 588-595
4. Pagel P.S. Remote exposure to xenon produces delayed preconditioning against myocardial infarction in vivo: Additional evidence that noble gases are not biologically inert. Anesth Analg 107 (2009) 1768-1771
5. Pagel P.S., Krolikowski J.G., Pratt Jr. P.F., et al. The mechanism of helium-induced preconditioning: A direct role for nitric oxide in rabbits. Anesth Analg 107 (2008) 762-768
6. Pagel P.S., Krolikowski J.G., Weihrauch D., et al. Inhibition of glycogen synthase kinase or the apoptotic protein p53 lowers the threshold of helium cardioprotection in vivo: The role of mitochondrial permeability transition. Anesth Analg 107 (2008) 769-775
7. ATP channels mediate helium-induced preconditioning against myocardial infarction in vivo. J Cardiothorac Vasc Anesth 22 (2008) 554-559
8. Hausenloy D.J., and Yellon D.M. Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc Res 70 (2006) 240-253
9. Pagel P.S. Postconditioning by volatile anesthetics: Salvaging ischemic myocardium at reperfusion by activation of prosurvival signaling. J Cardiothorac Vasc Anesth 22 (2008) 753-765
10. Pagel P.S., and Krolikowski J.G. Transient metabolic alkalosis during early reperfusion abolishes helium preconditioning against myocardial infarction: Restoration of cardioprotection by cyclosporin A in rabbits. Anesth Analg (2009) (in press)
11. 2+-sensitive potassium channel activation. Anesthesiology 109 (2008) 830-836
12. Gross E.R., and Gross G.J. Ligand triggers of classical preconditioning and postconditioning. Cardiovasc Res 70 (2006) 212-221
13. ATP channels and opioid receptors. Anesthesiology 98 (2003) 705-711
14. Warltier D.C., Zyvoloski M.G., Gross G.J., et al. Determination of experimental myocardial infarct size. J Pharmacol Methods 6 (1981) 199-210
15. Wallenstein S., Zucker C.L., and Fleiss J.L. Some statistical methods useful in circulation research. Circ Res 47 (1980) 1-9
16. ATP channels. Am J Physiol Heart Circ Physiol 274 (1998) H909-H914
17. Schultz J.J., Hsu A.K., and Gross G.J. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 78 (1996) 1100-1104
18. Fryer R.M., Pratt P.F., Hsu A.K., et al. Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection. J Pharmacol Exp Ther 296 (2001) 642-649
19. Gross E.R., Hsu A.K., and Gross G.J. The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3beta. Am J Physiol Heart Circ Physiol 291 (2006) H827-H834
20. ATP channel opening mediate acute opioid-induced cardioprotection at reperfusion. Basic Res Cardiol 102 (2007) 341-349
21. Gross E.R., Hsu A.K., and Gross G.J. Opioid-induced cardioprotection occurs via glycogen synthase kinase β inhibition during reperfusion in intact rat hearts. Circ Res 94 (2004) 960-966
22. Weihrauch D., Krolikowski J.G., Bienengraeber M., et al. Morphine enhances isoflurane-induced postconditioning against myocardial infarction: The role of phosphatidylinositol-3-kinase and opioid receptors in rabbits. Anesth Analg 101 (2005) 942-949
23. Fryer R.M., Hsu A.A., Nagase H., et al. Opioid-induced cardioprotection against myocardial infarction and arrhythmias: Mitochondrial versus sarcolemmal ATP-sensitive potassium channels. J Pharmacol Exp Ther 294 (2000) 451-457
24. Zatta A.J., Kin H., Yoshishige D., et al. Evidence that cardioprotection by postconditioning involves preservation of myocardial opioid content and selective opioid receptor activation. Am J Physiol Heart Circ Physiol 294 (2008) H1444-H1451
25. Zhang S.Z., Wang N.F., Xu J., et al. Kappa-opioid receptors mediate cardioprotection by remote preconditioning. Anesthesiology 105 (2006) 550-556
26. Peart J.N., Gross E.R., Reichelt M.E., et al. Activation of kappa-opioid receptors at reperfusion affords cardioprotection in both rat and mouse hearts. Basic Res Cardiol 103 (2008) 454-463
27. Xu Z., Yang X.M., Cohen M.V., et al. Limitation of infarct size in rabbit hearts by the novel adenosine receptor agonist AMP 579 administered at reperfusion. J Mol Cell Cardiol 32 (2000) 2339-2347
28. Yang X.M., Krieg T., Cui L., et al. NECA and bradykinin at reperfusion reduce infarction in rabbit hearts by signaling through PI3K, ERK, and NO. J Mol Cell Cardiol 36 (2004) 411-421
29. Hausenloy D.J., and Yellon D.M. New directions for protecting the heart against ischaemia-reperfusion injury: Targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 61 (2004) 448-460
30. Gross E.R., Hsu A.K., and Gross G.J. Diabetes abolishes morphine-induced cardioprotection via multiple pathways upstream of glycogen synthase kinase-3beta. Diabetes 56 (2007) 127-136
31. ATP channels. Circ Res 84 (1999) 1396-1400
32. ATP channels in myocytes. Circulation 103 (2001) 290-295
33. ATP channel opening. FASEB J 16 (2002) 1468-1470
34. Toller W.G., Kersten J.R., Gross E.R., et al. Isoflurane preconditions myocardium against infarction via activation of inhibitory guanine nucleotide binding proteins. Anesthesiology 92 (2000) 1400-1407
35. Maxwell M.P., Hearse D.J., and Yellon D.M. Species variation in the coronary collateral circulation during regional myocardial ischaemia: A critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res 21 (1987) 737-746